These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 29742692)
1. Five common tumor biomarkers and CEA for diagnosing early gastric cancer: A protocol for a network meta-analysis of diagnostic test accuracy. Shen M; Wang H; Wei K; Zhang J; You C Medicine (Baltimore); 2018 May; 97(19):e0577. PubMed ID: 29742692 [TBL] [Abstract][Full Text] [Related]
2. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy. Ge L; Pan B; Song F; Ma J; Zeraatkar D; Zhou J; Tian J BMJ Open; 2017 Dec; 7(12):e018175. PubMed ID: 29282264 [TBL] [Abstract][Full Text] [Related]
3. CT, MRI, and F-18 FDG PET for the detection of non-small-cell lung cancer (NSCLC): A protocol for a network meta-analysis of diagnostic test accuracy. Zhang Y; Ni J; Wei K; Tian J; Sun S Medicine (Baltimore); 2018 Sep; 97(38):e12387. PubMed ID: 30235705 [TBL] [Abstract][Full Text] [Related]
4. F-18 FDG PET, CT, and MRI for detecting the malignant potential in patients with gastrointestinal stromal tumors: A protocol for a network meta-analysis of diagnostic test accuracy. Wei K; Pan B; Yang H; Lu C; Ge L; Cao N Medicine (Baltimore); 2018 Apr; 97(16):e0389. PubMed ID: 29668594 [TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Mocellin S; Pasquali S Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD009944. PubMed ID: 25914908 [TBL] [Abstract][Full Text] [Related]
8. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer. Chen C; Chen Q; Zhao Q; Liu M; Guo J Ann Clin Lab Sci; 2017 May; 47(3):260-263. PubMed ID: 28667025 [TBL] [Abstract][Full Text] [Related]
9. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study. Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332 [TBL] [Abstract][Full Text] [Related]
10. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer. Gong X; Zhang H J Clin Lab Anal; 2020 Jul; 34(7):e23268. PubMed ID: 32118318 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of biomarkers for ovarian cancer: Protocol for an overview, evidence mapping, and adjusted indirect comparisons. Hua J; Liu J; Hua M; Cai R; Li M; Wang J; Wang J; Medicine (Baltimore); 2019 May; 98(18):e15508. PubMed ID: 31045839 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Walsh T; Macey R; Kerr AR; Lingen MW; Ogden GR; Warnakulasuriya S Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010276. PubMed ID: 34282854 [TBL] [Abstract][Full Text] [Related]
14. Clinical Evaluation of Serum Tumor Markers in the Diagnosis of Gastric Adenocarcinoma Staging and Grading. Ghaderi B; Moghbel H; Daneshkhah N; Babahajian A; Sheikhesmaeili F J Gastrointest Cancer; 2019 Sep; 50(3):525-529. PubMed ID: 29806060 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers for detecting prostate cancer: Protocol for an umbrella review with integrated network meta-analysis. Jia J; Sun Y; Ren J; Li M; Wang J; Li H; Medicine (Baltimore); 2019 Jul; 98(30):e16517. PubMed ID: 31348264 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population. So JBY; Kapoor R; Zhu F; Koh C; Zhou L; Zou R; Tang YC; Goo PCK; Rha SY; Chung HC; Yoong J; Yap CT; Rao J; Chia CK; Tsao S; Shabbir A; Lee J; Lam KP; Hartman M; Yong WP; Too HP; Yeoh KG Gut; 2021 May; 70(5):829-837. PubMed ID: 33028667 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Shimada H; Noie T; Ohashi M; Oba K; Takahashi Y Gastric Cancer; 2014 Jan; 17(1):26-33. PubMed ID: 23572188 [TBL] [Abstract][Full Text] [Related]
18. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer. Yin LK; Sun XQ; Mou DZ Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Liang Y; Wang W; Fang C; Raj SS; Hu WM; Li QW; Zhou ZW Oncotarget; 2016 Aug; 7(31):49565-49573. PubMed ID: 27385101 [TBL] [Abstract][Full Text] [Related]
20. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]